< Back to previous page
Researcher
Karin Haustermans
- Disciplines:Radiation therapy, Cancer diagnosis, Cancer therapy, Cancer epidemiology
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → Today
Infrastructure
1 - 1 of 1
- The PaRtiCLE proton center. (Consortium coordinator)
Projects
1 - 10 of 37
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Proton versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyFrom1 Jul 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- The importance of the TNM Classification for Cancer Surveillance.From20 Oct 2020 → 30 Apr 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate patient-individual prediction of proton therapy benefit in thoracic cancers using 3D dose maps and radiomicsFrom1 Oct 2020 → TodayFunding: FWO junior postdoctoral fellowship
- Characterization of the biological benefits of ultra-high dose rate FLASH proton therapy.From31 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organ preserving strategies in rectal cancerFrom10 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancerFrom6 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Upgrade of the proton research beam line in the ParTICLe proton therapy center into a high precision proton irradiator.From1 May 2020 → TodayFunding: BOF - scientific equipment program
- The PaRtiCLE proton center.From1 May 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCsFrom1 Jun 2019 → TodayFunding: H2020 - Euratom
Publications
1 - 10 of 303
- The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice(2023)
Authors: Karin Haustermans
- Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment(2023)
Authors: Lien Smets, Eva Oldenburger, Chantal Van Audenhove, Jeroen Dekervel, Albert Wolthuis, Karin Haustermans
- Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.(2023)
Authors: Philippe Nafteux, Karin Haustermans, Eric Van Cutsem
Pages: 21 - 28 - Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer(2022)
Authors: Pieter Populaire, Gilles Defraene, Karin Haustermans, Edmond Sterpin
Pages: 101 - 107 - High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer(2022)
Authors: Maarten Lambrecht, Karin Haustermans
- Potential Molecular Mechanisms behind the Ultra-High Dose Rate "FLASH" Effect(2022)
Authors: Ellina Macaeva, Sofie Isebaert, Karin Haustermans
- Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(2022)
Authors: Karin Haustermans
Pages: 1005 - 1020 - Who needs a mean dose if you can FLAME?(2022)
Authors: Karin Haustermans
Pages: 171 - 172 - Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study(2022)
Authors: Lien Smets, Albert Wolthuis, Jeroen Dekervel, Eric Van Cutsem, Christophe Deroose, Karin Haustermans
Pages: 113 - 120 - Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer(2022)
Authors: Karin Haustermans, Cédric Draulans, Sofie Isebaert
Pages: 252 - 257